These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
51 related articles for article (PubMed ID: 3954819)
21. Interactions of 2-methoxyestradiol, an endogenous mammalian metabolite, with unpolymerized tubulin and with tubulin polymers. Hamel E; Lin CM; Flynn E; D'Amato RJ Biochemistry; 1996 Jan; 35(4):1304-10. PubMed ID: 8573587 [TBL] [Abstract][Full Text] [Related]
22. Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain. Ravelli RB; Gigant B; Curmi PA; Jourdain I; Lachkar S; Sobel A; Knossow M Nature; 2004 Mar; 428(6979):198-202. PubMed ID: 15014504 [TBL] [Abstract][Full Text] [Related]
23. Experimental diabetes and platelet aggregation in the rat. Murray J; Kaneko JJ; Rucker RB Res Commun Chem Pathol Pharmacol; 1983 Aug; 41(2):283-91. PubMed ID: 6356254 [TBL] [Abstract][Full Text] [Related]
24. A novel method for chemical modification of functional groups other than a carboxyl group in proteins by N-ethyl-5-phenylisooxazolium-3'-sulfonate (Woodward's reagent-K): inhibition of ADP-induced platelet responses involves covalent modification of aggregin, an ADP receptor. Puri RN; Colman RW Anal Biochem; 1996 Sep; 240(2):251-61. PubMed ID: 8811919 [TBL] [Abstract][Full Text] [Related]
25. Binding of maytansine to tubulin: competition with other mitotic inhibitors. Lin CM; Hamel E; Wolpert-DeFilippes MK Res Commun Chem Pathol Pharmacol; 1981 Mar; 31(3):443-51. PubMed ID: 7255878 [TBL] [Abstract][Full Text] [Related]
27. Stereoselective inhibition of human platelet aggregation by R-138727, the active metabolite of CS-747 (prasugrel, LY640315), a novel P2Y12 receptor inhibitor. Hasegawa M; Sugidachi A; Ogawa T; Isobe T; Jakubowski JA; Asai F Thromb Haemost; 2005 Sep; 94(3):593-8. PubMed ID: 16268477 [TBL] [Abstract][Full Text] [Related]
28. New orally active non-peptide fibrinogen receptor (GpIIb-IIIa) antagonists: identification of ethyl 3-[N-[4-[4-[amino[(ethoxycarbonyl) imino]methyl]phenyl]-1,3-thiazol-2-yl]-N-[1-[(ethoxycarbonyl)methyl]pip erid -4-yl]amino]propionate (SR 121787) as a potent and long-acting antithrombotic agent. Badorc A; Bordes MF; de Cointet P; Savi P; Bernat A; Lalé A; Petitou M; Maffrand JP; Herbert JM J Med Chem; 1997 Oct; 40(21):3393-401. PubMed ID: 9341914 [TBL] [Abstract][Full Text] [Related]
29. Platelet aggregation and fibrinogen binding in human, rhesus monkey, guinea-pig, hamster and rat blood: activation by ADP and a thrombin receptor peptide and inhibition by glycoprotein IIb/IIIa antagonists. Cook NS; Zerwes HG; Tapparelli C; Powling M; Singh J; Metternich R; Hagenbach A Thromb Haemost; 1993 Sep; 70(3):531-9. PubMed ID: 8259560 [TBL] [Abstract][Full Text] [Related]
30. The hypolipidaemic activity of aqueous Erica multiflora flowers extract in Triton WR-1339 induced hyperlipidaemic rats: a comparison with fenofibrate. Harnafi H; Bouanani Nel H; Aziz M; Serghini Caid H; Ghalim N; Amrani S J Ethnopharmacol; 2007 Jan; 109(1):156-60. PubMed ID: 17092671 [TBL] [Abstract][Full Text] [Related]
31. Anti-mitotic activity of colchicine and the structural basis for its interaction with tubulin. Bhattacharyya B; Panda D; Gupta S; Banerjee M Med Res Rev; 2008 Jan; 28(1):155-83. PubMed ID: 17464966 [TBL] [Abstract][Full Text] [Related]
32. Inhibitors of ADP-induced platelet aggregation prevent fibrinogen binding to rabbit platelets and cause rapid deaggregation and dissociation of bound fibrinogen. Harfenist EJ; Packham MA; Kinlough-Rathbone RL; Mustard JF J Lab Clin Med; 1981 May; 97(5):680-8. PubMed ID: 6783712 [TBL] [Abstract][Full Text] [Related]
33. Effects of some antineoplastic drugs (vincristine, doxorubicin and epirubicin) on human platelet aggregation. Matera C; Falzarano C; Vacca C; Falciani M; Rossi F J Med; 1994; 25(1-2):2-16. PubMed ID: 7930957 [TBL] [Abstract][Full Text] [Related]
34. Hypolipidaemic activity of aqueous Ocimum basilicum extract in acute hyperlipidaemia induced by triton WR-1339 in rats and its antioxidant property. Amrani S; Harnafi H; Bouanani Nel H; Aziz M; Caid HS; Manfredini S; Besco E; Napolitano M; Bravo E Phytother Res; 2006 Dec; 20(12):1040-5. PubMed ID: 17006976 [TBL] [Abstract][Full Text] [Related]
35. [4-(imidazol-1-yl)thiazol-2-yl]phenylamines. A novel class of highly potent colchicine site binding tubulin inhibitors: synthesis and cytotoxic activity on selected human cancer cell lines. Mahboobi S; Sellmer A; Höcher H; Eichhorn E; Bär T; Schmidt M; Maier T; Stadlwieser JF; Beckers TL J Med Chem; 2006 Sep; 49(19):5769-76. PubMed ID: 16970401 [TBL] [Abstract][Full Text] [Related]
36. Inhibition of human and rat platelet aggregation by extracts of Mo-er (Auricularia auricula). Agarwal KC; Russo FX; Parks RE Thromb Haemost; 1982 Oct; 48(2):162-5. PubMed ID: 6983740 [TBL] [Abstract][Full Text] [Related]
37. The effect of 2-(4-methyl-1-piperazinylmethyl) acrylophenone dihydrochloride on the alkylation of tubulin. Luduena RF; Roach MC; Trcka PP; Mallevais ML; MacRae T Arch Biochem Biophys; 1987 Jun; 255(2):453-9. PubMed ID: 3592685 [TBL] [Abstract][Full Text] [Related]
38. Synthesis of β-Amino Diaryldienones Using the Mannich Reaction. Elshan NGRD; Rettig MB; Jung ME Org Lett; 2019 Jun; 21(11):4039-4043. PubMed ID: 31081633 [TBL] [Abstract][Full Text] [Related]
39. Chemical and pharmacological studies of 2-(amino-methyl)acrylophenones. Lesieur I; Lesieur D; Lespagnol C; Cazin M; Brunet C; Luyckx M; Mallevais ML; Delacourte A; Dubreuil L; Devos J Arzneimittelforschung; 1986; 36(1):20-4. PubMed ID: 3954819 [TBL] [Abstract][Full Text] [Related]
40. Normolipemic activities of acrylophenone derivatives with antimicrotubular properties. Bard JM; Luyckx M; Brunet C; Cazin M; Fruchart JC; Clavey V; Lesieur I; Lesieur D; Delacourte A Methods Find Exp Clin Pharmacol; 1985 Apr; 7(4):183-7. PubMed ID: 4021650 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]